Literature DB >> 11226853

Immunity and protection against Brucella abortus.

B Golding1, D E Scott, O Scharf, L Y Huang, M Zaitseva, C Lapham, N Eller, H Golding.   

Abstract

Brucella abortus is an intracellular pathogen that causes disease in cattle and in humans. The response against B. abortus involves the whole gamut of the immune system, from innate to adaptive immunity resulting from stimulation of antigen-presenting cells, NK cells, CD4(+) and CD8(+) T cells, and B cells.

Entities:  

Mesh：

Year:  2001        PMID： 11226853     DOI： 10.1016/s1286-4579(00)01350-2

Source DB:  PubMed          Journal:  Microbes Infect        ISSN： 1286-4579            Impact factor:   2.700


  67 in total

1.  Evaluation of protection afforded by Brucella abortus and Brucella melitensis unmarked deletion mutants exhibiting different rates of clearance in BALB/c mice.

Authors:  M M Kahl-McDonagh; T A Ficht
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

2.  Immunization with a single dose of a microencapsulated Brucella melitensis mutant enhances protection against wild-type challenge.

Authors:  Angela M Arenas-Gamboa; Thomas A Ficht; Melissa M Kahl-McDonagh; Allison C Rice-Ficht
Journal:  Infect Immun       Date:  2008-03-24       Impact factor: 3.441

3.  Brucella abortus phosphoglyceromutase and dihydrodipicolinate reductase induce Th1 and Th2-related immune responses.

Authors:  Zhiqiang Li; Hui Zhang; Jinliang Zhang; Li Xi; Guangli Yang; Shuli Wang; Qingfeng Zhou; Xiaogen Zhang; Junbo Zhang
Journal:  World J Microbiol Biotechnol       Date:  2018-01-04       Impact factor: 3.312

4.  TLR2 and TLR4 signaling pathways are required for recombinant Brucella abortus BCSP31-induced cytokine production, functional upregulation of mouse macrophages, and the Th1 immune response in vivo and in vitro.

Authors:  Jia-Yun Li; Yuan Liu; Xiao-Xue Gao; Xiang Gao; Hong Cai
Journal:  Cell Mol Immunol       Date:  2014-04-28       Impact factor: 11.530

Review 5.  The role of NLRP3 and AIM2 in inflammasome activation during Brucella abortus infection.

Authors:  Fernanda M Marim; Miriam M Costa Franco; Marco Tulio R Gomes; Maria Cruz Miraglia; Guillermo H Giambartolomei; Sergio C Oliveira
Journal:  Semin Immunopathol       Date:  2016-07-12       Impact factor: 9.623

6.  The Brucella melitensis M5-90 phosphoglucomutase (PGM) mutant is attenuated and confers protection against wild-type challenge in BALB/c mice.

Authors:  Yu Zhang; Tiansen Li; Jing Zhang; Zhiqiang Li; Yan Zhang; Zhen Wang; Hanping Feng; Yuanzhi Wang; Chuangfu Chen; Hui Zhang
Journal:  World J Microbiol Biotechnol       Date:  2016-02-29       Impact factor: 3.312

7.  A DNA vaccine encoding Cu,Zn superoxide dismutase of Brucella abortus induces protective immunity in BALB/c mice.

Authors:  Angel A Oñate; Sandra Céspedes; Alex Cabrera; Rodolfo Rivers; Andrés González; Carola Muñoz; Hugo Folch; Edilia Andrews
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

8.  A potent Brucella abortus 2308 Δery live vaccine allows for the differentiation between natural and vaccinated infection.

Authors:  Junbo Zhang; Shuanghong Yin; Fei Guo; Ren Meng; Chuangfu Chen; Hui Zhang; Zhiqiang Li; Qiang Fu; Huijun Shi; Shengwei Hu; Wei Ni; Tiansen Li; Ke Zhang
Journal:  J Microbiol       Date:  2014-07-04       Impact factor: 3.422

9.  Gamma/delta T cells in patients with acute brucellosis.

Authors:  S S Kilic; H H Akbulut; M Ozden; V Bulut
Journal:  Clin Exp Med       Date:  2008-12-02       Impact factor: 3.984

10.  Evaluation of recombinant invasive, non-pathogenic Eschericia coli as a vaccine vector against the intracellular pathogen, Brucella.

Authors:  Jerome S Harms; Marina A Durward; Diogo M Magnani; Gary A Splitter
Journal:  J Immune Based Ther Vaccines       Date:  2009-01-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.